In recent years, several paediatric monophasic and multiphasic immune-mediated acquired demyelinating syndromes (ADS) like acute disseminated encephalomyelitis, optic neuritis and transverse myelitis have been shown to be associated with the presence of antibodies targeting myelin oligodendrocyte glycoprotein (MOG-ab), a small yet important component of the myelin sheet. Importantely, this entity here called MOG- associated diseases (MOGAD), is clearly distinct from other diseases such as childhood MS or AQP4 associated NMOSD. This webinar will therefore primarily address clinical relevant aspects of this y new disease entity such as role of MOG abs in the disease process, which technique to use for MOG-abs testing, spectrum of monophasic/multiphasic diseases associated with MOG antibodies, how to treat children with MOGAD in addition remaining open questions.
EPNS Visiting Teacher 2021: The EPNS is once again thrilled to be able to offer 2 opportunities. The closing date is 1 November 2020. More details about the scheme, together with the application form, can be found by visiting the EPNS website https://www.epns.info/epns-visiting-teacher-2021/
Allow me to draw your attention to the attached document, already available on the ILAE website (https://www.ilae.org/patient-care/covid-19-and-epilepsy), including very useful information on possibly clinically relevant drug-drug interactions between AEDs and medications used in the treatment of COVID-19 patients.